Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.7300 (-1.8%) ($14.3300 - $15.3200) on Tue. Sep. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 69 | Latest Price | $14.7300(-1.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.925% in a week (0% probabilities). VIXM(-36%) VXX(-34%) TLT(-12%) UNG(-7%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $15.2(-3.09%) | 10 Day Moving Average | $15.35(-4.04%) | 20 Day Moving Average | $14.61(0.82%) | To recent high | -27.9% | To recent low | 22.4% | Market Cap | $1.095b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |